Run away from this - this company focuses on one specific compounding segment (transdermal pain creams) which has high margins. What do you think insurance companies are going to do when they see this exploited as big players like Bellevue hire reps all over God's green earth? They cut reimbursement or stop covering compounded medications completely. Then what happens? Bellevue is a one-trick pony and it is going to crash and burn in a spectacular fashion when the reimbursement for these medications gets slashed or is no longer covered.